Page 1

The Lindesmith Center’s SPECIAL DRUG POLICY SEMINAR SERIES Summer and Fall 1996 DRUG TREATMENT RECONSIDERED: HARM REDUCTION PERSPECTIVES The Lindesmith Center is presenting a special seminar series on the relationship between drug treatment and harm reduction. Harm reduction services focus on reducing the negative consequences of drug use among those unwilling or unable to abstain….

Herman Joseph, PhD 1931 – 2019 NAMA Recovery    Press Release    May 28, 2019  |  0 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in…

DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act April 15, 2022 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which…

Methadone Advocacy: The Time Has Come There are many approaches that a methadone advocacy organization can utilize to bring about change. TexNAMA’s primary objective (as part of NAMA) is the empowerment of patients. By confronting the negative stereotypes TexNAMA works to end the stigma and discrimination that has made recovery and reintegration back into society…

AMTA Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Preconference Meeting How Can We Develop and Strengthen Patient Advocacy Groups? Day: Sunday Date: April 9, 2000 Time: 1 – 5 PM Moderator: John Finger, TexNAMA Presenters: Joycelyn Woods, NAMA Diane Fleury-Seaman, MALTA Fred Christie, AFIRM James DePasquale, Membership Director/Chapter Coordinator of NAMA…

Press Release July 22, 1999 National Alliance of Methadone Advocates NAMA 435 Second Avenue New York, NY 10010 Email: [email protected] NAMA applauds the hard work of SAMHSA, the ONDCP, NIDA and CSAT for the release of the New Accreditation Guidelines for Methadone and LAAM Treatment. We are aware that these agencies have made tremendous efforts…